Nov.2023Vol.47No.6•234•ChineseJournalofLibraryandInformationScienceforTraditionalChineseMedicine【引文格式】王留芳,唐玉君,蒋士卿,等.精元康方治疗中晚期恶性肿瘤研究进展[J].中国中医药图书情报杂志,2023,47(6):234-236,封三.·综述·精元康方治疗中晚期恶性肿瘤研究进展王留芳1,唐玉君1,蒋士卿2,蒋立峰31.河南中医药大学,河南郑州450000;2.河南中医药大学第一附属医院,河南郑州450000;3.河南省肿瘤医院,河南郑州450000摘要:中医药在改善恶性肿瘤患者临床症状、提高放化疗疗效、降低毒副作用、延长生存期等方面疗效显著。本文基于温阳解毒法就精元康方治疗中晚期恶性肿瘤相关基础研究及临床研究做一综述,以期为临床治疗恶性肿瘤提供参考。关键词:温阳解毒法;精元康;中晚期恶性肿瘤;可行性;综述中图分类号:R273文献标识码:A文章编号:2095-5707(2023)06-0234-04DOI:10.3969/j.issn.2095-5707.202210003开放科学(资源服务)标识码(OSID):ResearchProgressofJingyuankangPrescriptiononTreatmentofMiddleandAdvancedMalignantTumorsWANGLiufang1,TANGYujun1,JIANGShiqing2,JIANGLifeng3(1.HenanUniversityofChineseMedicine,Zhengzhou450000,China;2.TheFirstAffiliatedHospitalofHenanUniversityofCM,Zhengzhou450000,China;3.HenanCancerHospital,Zhengzhou450000,China)Abstract:TCMiseffectiveinimprovingtheclinicalsymptomsofpatientswithmalignanttumors,improvingtheefficacyofradiotherapyandchemotherapy,reducingtoxicandsideeffects,andprolongingsurvivaltime.ThisarticlereviewedthebasicresearchandclinicalresearchprogressofJingyuankangPrescriptioninthetreatmentofmiddleandadvancedmalignanttumorsbasedonthemethodofwarmingyangdetoxification,inordertoprovidereferenceforclinicaltreatmentofmalignanttumors.Keywords:warmyangdetoxificationmethod;JingyuankangPrescription;middleandadvancedmalignanttumors;feasibility;review调查显示,2020年全球恶性肿瘤新发病例约1929万例,死亡病例约996万例,中国分别约占23.7%和30%,发病率和病死率均高于全球平均水平[1]。由于人口老龄化、工业化、城市化进程加剧,生活方式改变等原因,中国癌症负担仍会增加[2]。恶性肿瘤患者确诊时中晚期居多,无法进行根治手术,放化疗及分子靶向、免疫疗法等治疗手段为中晚期患者带来了希望,但易引起骨...